Related Experiment Video
Updated: May 24, 2025
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
1.8K
Single-cell spatial immune profiling for precision immunotherapy in Lynch syndrome.
Ramadhani Chambuso1, Stephene S Meena2
1Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, United States.
Journal of the National Cancer Center
|March 5, 2025
Summary
Lynch syndrome colorectal cancer (LS-CRC) has unique tumor immunology. Analyzing spatial tumor-infiltrating lymphocytes (TILs) with whole slide images can personalize immunotherapy for better LS-CRC patient outcomes.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) predisposition.
- LS-associated CRC (LS-CRC) exhibits high mutational burden and microsatellite instability-high (MSI-H) tumors.
- LS-CRC immunology is distinct, influencing immunotherapy response.
Purpose of the Study:
- To discuss a novel approach for analyzing spatial tumor-infiltrating lymphocytes (TILs) in LS-CRC.
- To highlight the importance of personalized medicine in hereditary cancer syndromes.
- To inspire future research and clinical practices for LS-CRC patients.
Main Methods:
- Analysis of spatial TILs at a single-cell level.
- Utilizing tumor whole slide images (WSIs).
- Accounting for the distinct tumor microenvironment (TME) in LS-CRC.
Main Results:
- LS-CRC benefits from immunotherapy due to its unique TME and TILs.
- Variability in immunotherapy response necessitates tailored approaches.
- Spatial TIL analysis offers a novel perspective on LS-CRC immunology.
Conclusions:
- Personalized immunotherapy approaches are crucial for LS-CRC patients.
- Spatial TIL analysis using WSIs can refine treatment strategies.
- Precision oncology holds promise for improving outcomes in hereditary CRC.
